KATPChannel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes
Author(s) -
Kasper Aaboe,
Filip K. Knop,
Tina Vilsbøll,
Aage Vølund,
Ulf Simonsen,
Carolyn F. Deacon,
Sten Madsbad,
Jens J. Holst,
Thure Krarup
Publication year - 2008
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2008-1731
Subject(s) - medicine , endocrinology , incretin , gastric inhibitory polypeptide , insulin , type 2 diabetes , diabetes mellitus , glipizide , glucagon like peptide 1 , hormone , glucagon , glucose clamp technique , pancreatic hormone , insulin resistance
The reduced incretin effect in subjects with type 2 diabetes is accompanied by a severely impaired insulinotropic effect of the incretin hormone glucose-dependent insulinotropic polypeptide (GIP). The K(ATP) channels of the beta-cell appear to be essential for the function of GIP in mice, and mutations in the gene encoding these channels have been linked to the development of type 2 diabetes. With this study we therefore aimed at clarifying the role of K(ATP) channel malfunction in the impaired function of GIP.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom